Reliability Optimization for Manufacturing Industries Using Variant of Heuristic and Meta Heuristic Techniques
Loading...
Date
item.page.authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
In fast growing industrialization, industries are competing to manufacture the best quality
newlinegoods to meet global standards. In order to manufacture needed goods in a stipulated time
newlineframe without affecting manpower and maintaining profit goals, it is required for a system
newlineto perform well. Here the term reliability has its importance; reliability is the probability
newlineof successful performances of a system in a specific given time duration. Reliability
newlineoptimization is a way to achieve desired levels of system reliability by employing several
newlineapproaches. Redundancy allocation is one of those approaches that work on the tradition of
newlineproviding additional components to the system for achieving the goals of reliability
newlineoptimization within the given constraints. Redundancies allocated to the system work as
newlinebackups that get activated on requirement or component/system failure and extend the
newlinesystem s life. Among the reliability optimization problems, the redundancy allocation
newlineproblem aims to identify the number of redundant components along with the component s
newlinereliability in efforts to maximize system reliability within the given constraints.
newlineThe research work presented in this thesis focuses on reliability optimization of
newlinemanufacturing systems using variants of heuristic and meta-heuristic techniques. The
newlinereliability optimization problems considered in the present research work are of three
newlinemanufacturing industries: one is Yaris Pharmaceuticals, from which considered two
newlinesystems are quotliquid medicine manufacturing systemsquot and quottablet medicine manufacturing
newlinesystemquot and the other two manufacturing industries are taken from existing literature
newlineknown as quotNeel Metal Products Limited 1A (NMPL-1A)quot (Devi and Garg, 2020) and
newlinequotPharmaceutical Plantquot (Garg et al., 2010).